REQUEST A DEMO
Total
USD $0.00
Search more companies

Pfizer Pharmaceutical Korea Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pfizer Pharmaceutical Korea Ltd. Profile Updated: October 23, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Pfizer Pharmaceutical Korea Ltd. is engaged in supply and distribution of biopharmaceutical products, veterinary medicines and consumer healthcare items. The company offers medicines and pharmaceutical products used to treat/cure cardiovascular diseases, cancer, Alzheimer's diseases, mental and neurological disorders, among others. Pfizer Pharmaceutical Korea Ltd. is based in Seoul, South Korea. The company was established in 1959 and operates as a subsidiary of Pfizer Inc.

Headquarters
100, Toegye-ro Jung-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Pfizer Pharmaceutical Korea Ltd. report to view the information.

Website: http://www.pfizer.co.kr

Basic Information
Total Employees:
Purchase the Pfizer Pharmaceutical Korea Ltd. report to view the information.
Outstanding Shares:
Purchase the Pfizer Pharmaceutical Korea Ltd. report to view the information.
Registered Capital:
Purchase the Pfizer Pharmaceutical Korea Ltd. report to view the information.
Incorporation Date:
June 16, 1959
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
50.1%
Purchase this report to view the information.
49.3%
Subsidiaries
PHARMACIA KOREA LTD.
ZOETIS KOREA LTD.
Company Performance
Financial values in the chart are available after Pfizer Pharmaceutical Korea Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
90.41%
Total operating revenue
90.41%
Operating profit (EBIT)
102.81%
EBITDA
100.85%
Net Profit (Loss) for the Period
24.53%
Total assets
25.21%
Total equity
46.68%
Operating Profit Margin (ROS)
0.22%
Net Profit Margin
-1.96%
Return on Equity (ROE)
-5.58%
Quick Ratio
0.07%
Cash Ratio
0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?